InsidersTradesSigma
Follow the CYTOKINETICS, INCORPORATED stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €10.8bn. The latest transaction was filed on 30 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Sung Lee. Every trade is accessible without an account.
Analysts rate CYTOKINETICS, INCORPORATED Strong Buy (bullish), based on 20 analysts. Average price target: US$109.90.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
CYTOKINETICS, INCORPORATED 是一家生物制药公司，专注于开发肌肉和心脏疾病的治疗方法。它采用创新方法来增强肌肉功能和身体表现。